« Previous
Next »
Journal of Diabetes and Its Complications
Volume 25, Issue 2
, Pages 83-89
, March 2011
Improvement in bedtime plasma glucose level serves as a predictor of long-term blood glucose control in patients with Type 2 diabetes: a study with monotherapy of 50/50 premixed insulin analogue three times daily injection
References
- . Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production. Diabetes. 1996;45:1044–1050
- . Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in Type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. Journal of Clinical Endocrinology and Metabolism. 2006;91:813–819
- . Addition of neutral protamine lispro or insulin glargine to oral Type 2 diabetes regimens for patients with suboptimal glycemic control. A randomized trial. Annals of Internal Medicine. 2008;149:531–539
- . Acarbose reduces the risk for myocardial infraction in Type 2 diabetic patients: meta-analysis of seven long-term studies. European Heart Journal. 2004;25:10–16
- . Improvement of glycemic control and quality-of-life by insulin lispro therapy: assessing benefits by ITR-QOL questionnaires. Diabetes Research and Clinical Practice. 2008;81:169–178
- . Quality of life in insulin-treated patients. Journal of Japan Diabetes Society. 2008;51:601–608(in Japanese)
- . Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trials in patients with Type 2 diabetes beginning insulin therapy. Journal of Diabetes and its Complications. 2006;20:145–152
- . Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of Type 2 diabetic patients. Diabetes Care. 2003;26:881–885
- . Twenty-four hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. Journal of Clinical Investigation. 1988;81:442–448
- . Mealtime 50/50 basal+prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels on patients with Type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison. Clinical Therapeutics. 2007;29:2349–2364
- . Advancing insulin therapy in Type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy. Diabetes Care. 2008;31:20–25
- . A randomized, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naïve people with Type 2 diabetes. Diabetologia. 2008;51:408–416
- . Efficacy of conversion from bedtime NPH insulin to morning insulin glargine in Type 2 diabetic patients on basal-prandial insulin therapy. Diabetes Research and Clinical Practice. 2006;73:35–40
PII: S1056-8727(10)00049-8
doi: 10.1016/j.jdiacomp.2010.05.001
© 2011 Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Diabetes and Its Complications
Volume 25, Issue 2
, Pages 83-89
, March 2011
